查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513221

2024 年基层医疗POC 诊断全球市场报告

Primary Care POC Diagnostics Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

基层医疗POC 诊断市场规模预计在未来几年将强劲成长。预计到 2028 年将以 7.8% 的复合年增长率增长至 221.9 亿美元。预测期内的预期增长是由感染疾病爆发的出现、非传染性疾病中 POC 诊断的使用增加、居家医疗环境的采用增加、精准医疗计划的进步、医疗基础设施投资的增加以及疾病负担所推动的。这被认为是由于多种因素造成的，包括患有癌症的人数增加以及人们对早期疾病检测重要性的认识增强。预测期内预计的主要趋势包括人工智慧（AI）和机器学习演算法的整合、分子诊断技术的进步、POC诊断设备的小型化和便携性的提高、智慧型装置的整合以及POC诊断的使用。復用和麵板测试。

预计感染疾病的增加将在短期内推动基层医疗POC 诊断市场的扩张。感染疾病是由细菌、病毒、真菌和寄生虫等病原微生物引起的，透过直接或间接接触受污染的表面、空气、水或昆虫等媒介传播。导致传播的因素包括恶劣的环境条件、都市化、抗菌素抗药性和疫苗接种不足。基层医疗POC 诊断透过在各种医疗机构中实现早期发现、及时治疗和有效的疾病管理，在应对这些感染疾病的增长方面发挥着重要作用。例如，2023年10月，健康安全局的报告显示，英国的爱滋病毒诊断人数将增加22%，从2021年的3,118人增加到2022年的3,805人。此外，2023年11月，世界卫生组织（WHO）报告称，2022年全球结核病病例数约为1,060万人，不同族群的感染人数达数百万人。因此，感染疾病的激增正在推动基层医疗POC 诊断市场的发展。

基层医疗POC 诊断市场的领导者正在专注于先进的技术解决方案，例如携带式照护现场RT-PCR 系统，以优化市场收益。这些系统专为传统实验室以外的即时逆转录聚合酵素链锁反应(RT-PCR) 测试而设计，具有移动性和紧凑性。例如，Genes2Me Pvt. Ltd 于 2022 年 10 月推出了 Rapi-Q Point of Care RT PCR 解决方案。 Rapi-Q 系统可携式，适用于医院、血库、诊所、实验室和机场等各种环境。它具有高灵敏度、高精度、高效能，相容于50多种疾病检测套件，可冷冻干燥、常温保存。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球基层医疗POC 诊断市场：驱动因素和限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球基层医疗POC 诊断市场表现：规模与成长，2018-2023 年
  • 全球基层医疗POC 诊断市场预测：规模与成长，2023-2028 年，2033F

第六章 市场细分

  • 全球基层医疗POC 诊断市场：按产品分類的绩效和预测，2018-2023、2023-2028F、2033F
  • 血糖监测
  • 心臟代谢测试产品
  • 传染病检查产品
  • 血液凝固检验产品
  • 怀孕和生育测试产品
  • 肿瘤或癌症标记检测产品
  • 胆固醇检测产品
  • 血液检测产品
  • 滥用药物 (DOA) 检测产品
  • 其他产品
  • 全球基层医疗POC 诊断市场：按处方笺的实际情况和预测，2018-2023、2023-2028F、2033F
  • 根据处方笺
  • 非处方药 (OTC) 测试
  • 全球基层医疗POC 诊断市场：按最终用途分類的实际情况和预测，2018-2023、2023-2028F、2033F
  • 医院
  • 诊断中心
  • 研究室
  • 居家照护环境
  • 其他用途

第 7 章 区域/国家分析

  • 全球基层医疗POC 诊断市场：按地区分類的表现和预测，2018-2023、2023-2028F、2033F
  • 全球基层医疗POC 诊断市场：按国家/地区分類的绩效和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 基层医疗POC诊断市场：竞争格局
  • 基层医疗POC 诊断市场：公司简介
    • Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Becton, Dickinson And Company
    • bioMerieux SA

第31章 其他大型创新企业

  • Quidel Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Nova Biomedical Corporation
  • Randox Laboratories Ltd
  • Ortho Clinical Diagnostics
  • Nipro Corporation
  • OraSure Technologies
  • Meridian Bioscience Inc
  • DiaSorin SpA
  • Sekisui Diagnostics LLC
  • EKF Diagnostics Holdings plc
  • Trinity Biotech plc
  • Fujirebio Diagnostics Inc.
  • Immunodiagnostic Systems Holdings PLC

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r18208

A point-of-care (POC) diagnostic in primary care entails conducting medical tests or evaluations conveniently and swiftly within a primary care environment, such as a doctor's office or clinic, without the need for specialized equipment or extensive laboratory processing. These diagnostics aim to deliver prompt results, enabling healthcare providers to make timely decisions regarding patient care during the initial consultation.

Primary care POC diagnostics encompass a range of products, including glucose monitoring, cardiometabolic testing products, infectious disease testing products, coagulation testing products, pregnancy and fertility testing products, tumor or cancer marker testing products, cholesterol testing products, hematology testing products, drug-of-abuse (DOA) testing products, among others. Glucose monitoring involves measuring blood glucose levels to manage diabetes and is available in different types such as prescription-based and over-the-counter (OTC) testing. These are utilized across various settings, including hospitals, diagnostic centers, research laboratories, home-care settings, and others.

The primary care POC diagnostics market research report is one of a series of new reports from The Business Research Company that provides primary care POC diagnostics market statistics, including primary care POC diagnostics industry global market size, regional shares, competitors with a primary care POC diagnostics market share, detailed primary care POC diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the primary care POC diagnostics industry. This primary care POC diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The primary care POC diagnostics market size has grown strongly in recent years. It will grow from $15.32 billion in 2023 to $16.46 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth observed in the historical period can be ascribed to several factors, including the rising prevalence of chronic diseases, a shift towards personalized medicine, increased healthcare spending, the implementation of supportive regulatory frameworks, streamlined approval processes, and a heightened focus on early disease detection and prevention strategies.

The primary care POC diagnostics market size is expected to see strong growth in the next few years. It will grow to $22.19 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. the anticipated growth in the forecast period can be attributed to various factors such as the emergence of infectious disease outbreaks, the expanding use of POC diagnostics in non-communicable diseases, greater adoption in home healthcare settings, advancements in precision medicine initiatives, augmented investments in healthcare infrastructure, escalating disease burden, and heightened awareness regarding the significance of early disease detection. Key trends expected in the forecast period include the integration of artificial intelligence (AI) and machine learning algorithms, advancements in molecular diagnostics technologies, the miniaturization and enhanced portability of POC diagnostic devices, the integration of smart devices, and the utilization of multiplexing and panel testing in POC diagnostics.

The anticipated increase in infectious diseases is poised to drive the expansion of the primary care POC diagnostics market in the foreseeable future. Infectious diseases, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, spread through direct or indirect contact with contaminated surfaces, air, water, or vectors such as insects. Factors contributing to their prevalence include poor environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage. Primary care POC diagnostics play a crucial role in addressing this rise in infectious diseases by enabling early detection, timely treatment, and effective disease control across various healthcare settings. For example, in October 2023, a report from the UK Health Security Agency revealed a 22% increase in HIV diagnoses in England from 3,118 in 2021 to 3,805 in 2022. Additionally, in November 2023, the World Health Organization reported approximately 10.6 million cases of tuberculosis globally in 2022, affecting millions across different demographics. Thus, the surge in infectious diseases is propelling the primary care POC diagnostics market forward.

Leading companies in the primary care POC diagnostics market are concentrating on advanced technological solutions, such as portable point-of-care RT-PCR systems, to optimize their market revenue. These systems, designed for real-time reverse transcription polymerase chain reaction (RT-PCR) tests outside traditional laboratories, offer mobility and compactness. For instance, Genes2Me Pvt. Ltd. introduced the Rapi-Q Point of Care RT PCR solution in October 2022, featuring an eight-well block design with four fluorescent channels, claimed to deliver rapid results in under 45 minutes. Portable and lightweight, the Rapi-Q system is suitable for various settings such as hospitals, blood banks, health clinics, research laboratories, and airports. It boasts high sensitivity, accuracy, and performance in disease detection, compatible with over 50 lyophilized, room-temperature disease detection kits.

In February 2021, Thermo Fisher Scientific Inc., a US-based biotechnology firm, acquired Mesa Biotech Inc. for about $450 million, bolstering its molecular diagnostics capabilities, particularly in POC testing, and enhancing its portfolio of infectious disease diagnostic solutions. Mesa Biotech Inc., a US-based molecular diagnostic company, specializes in primary care point-of-care tests and platforms.

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

North America was the largest region in the primary care POC diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the primary care POC diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary care POC diagnostics market consists of sales of respiratory pathogen testing products, thyroid function testing products, electrolyte testing products, and liver function testing products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Primary Care POC Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on primary care POC diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for primary care POC diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The primary care POC diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products
  • 2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing
  • 3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses
  • Companies Mentioned: Hoffmann-La Roche Ltd; Abbott Laboratories; Siemens Healthineers AG; Becton, Dickinson And Company; bioMerieux SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Primary Care POC Diagnostics Market Characteristics

3. Primary Care POC Diagnostics Market Trends And Strategies

4. Primary Care POC Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Primary Care POC Diagnostics Market Size and Growth

  • 5.1. Global Primary Care POC Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Primary Care POC Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Primary Care POC Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Primary Care POC Diagnostics Market Segmentation

  • 6.1. Global Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Glucose Monitoring
  • Cardiometabolic Testing Products
  • Infectious Disease Testing Products
  • Coagulation Testing Products
  • Pregnancy And Fertility Testing Products
  • Tumor Or Cancer Marker Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drug-Of-Abuse (DOA) Testing Products
  • Other Products
  • 6.2. Global Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prescription Based
  • Over-The-Counter (OTC) Testing
  • 6.3. Global Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Home-Care Settings
  • Other End-Uses

7. Primary Care POC Diagnostics Market Regional And Country Analysis

  • 7.1. Global Primary Care POC Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Primary Care POC Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Primary Care POC Diagnostics Market

  • 8.1. Asia-Pacific Primary Care POC Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Primary Care POC Diagnostics Market

  • 9.1. China Primary Care POC Diagnostics Market Overview
  • 9.2. China Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Primary Care POC Diagnostics Market

  • 10.1. India Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Primary Care POC Diagnostics Market

  • 11.1. Japan Primary Care POC Diagnostics Market Overview
  • 11.2. Japan Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Primary Care POC Diagnostics Market

  • 12.1. Australia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Primary Care POC Diagnostics Market

  • 13.1. Indonesia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Primary Care POC Diagnostics Market

  • 14.1. South Korea Primary Care POC Diagnostics Market Overview
  • 14.2. South Korea Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Primary Care POC Diagnostics Market

  • 15.1. Western Europe Primary Care POC Diagnostics Market Overview
  • 15.2. Western Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Primary Care POC Diagnostics Market

  • 16.1. UK Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Primary Care POC Diagnostics Market

  • 17.1. Germany Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Primary Care POC Diagnostics Market

  • 18.1. France Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Primary Care POC Diagnostics Market

  • 19.1. Italy Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Primary Care POC Diagnostics Market

  • 20.1. Spain Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Primary Care POC Diagnostics Market

  • 21.1. Eastern Europe Primary Care POC Diagnostics Market Overview
  • 21.2. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Primary Care POC Diagnostics Market

  • 22.1. Russia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Primary Care POC Diagnostics Market

  • 23.1. North America Primary Care POC Diagnostics Market Overview
  • 23.2. North America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Primary Care POC Diagnostics Market

  • 24.1. USA Primary Care POC Diagnostics Market Overview
  • 24.2. USA Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Primary Care POC Diagnostics Market

  • 25.1. Canada Primary Care POC Diagnostics Market Overview
  • 25.2. Canada Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Primary Care POC Diagnostics Market

  • 26.1. South America Primary Care POC Diagnostics Market Overview
  • 26.2. South America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Primary Care POC Diagnostics Market

  • 27.1. Brazil Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Primary Care POC Diagnostics Market

  • 28.1. Middle East Primary Care POC Diagnostics Market Overview
  • 28.2. Middle East Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Primary Care POC Diagnostics Market

  • 29.1. Africa Primary Care POC Diagnostics Market Overview
  • 29.2. Africa Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Primary Care POC Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Primary Care POC Diagnostics Market Competitive Landscape
  • 30.2. Primary Care POC Diagnostics Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Ltd
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton, Dickinson And Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. bioMerieux SA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Primary Care POC Diagnostics Market Other Major And Innovative Companies

  • 31.1. Quidel Corporation
  • 31.2. Sysmex Corporation
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Nova Biomedical Corporation
  • 31.5. Randox Laboratories Ltd
  • 31.6. Ortho Clinical Diagnostics
  • 31.7. Nipro Corporation
  • 31.8. OraSure Technologies
  • 31.9. Meridian Bioscience Inc
  • 31.10. DiaSorin SpA
  • 31.11. Sekisui Diagnostics LLC
  • 31.12. EKF Diagnostics Holdings plc
  • 31.13. Trinity Biotech plc
  • 31.14. Fujirebio Diagnostics Inc.
  • 31.15. Immunodiagnostic Systems Holdings PLC

32. Global Primary Care POC Diagnostics Market Competitive Benchmarking

33. Global Primary Care POC Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Primary Care POC Diagnostics Market

35. Primary Care POC Diagnostics Market Future Outlook and Potential Analysis

  • 35.1 Primary Care POC Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Primary Care POC Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Primary Care POC Diagnostics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer